AIN HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,946 JPY | +2.04% |
|
+0.27% | +32.90% |
| Sales 2024 * | 397B 2.53B | Sales 2025 * | 421B 2.68B | Capitalization | 204B 1.3B |
|---|---|---|---|---|---|
| Net income 2024 * | 10.47B 66.67M | Net income 2025 * | 10.29B 65.51M | EV / Sales 2024 * | 0.4 x |
| Net cash position 2024 * | 46.9B 299M | Net cash position 2025 * | 55.1B 351M | EV / Sales 2025 * | 0.35 x |
| P/E ratio 2024 * |
19.6
x | P/E ratio 2025 * |
19.9
x | Employees | 10,561 |
| Yield 2024 * |
1.05% | Yield 2025 * |
1.12% | Free-Float | 76.47% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.04% | ||
| 1 week | +0.27% | ||
| Current month | -0.40% | ||
| 1 month | -1.15% | ||
| 3 months | +24.16% | ||
| 6 months | +38.15% | ||
| Current year | +32.90% |
1 week
5 763.00
6 009.00
1 month
5 763.006 268.00
Current year
4 353.006 268.00
1 year
4 023.006 268.00
3 years
4 023.008 350.00
5 years
4 023.008 610.00
10 years
2 212.509 330.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hideki Fujiwara
DFI | Director of Finance/CFO | - | - |
Kiichi Otani
PSD | President | 72 | 80-06-30 |
Takanobu Murase
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Junro Ito
BRD | Director/Board Member | 65 | 19-06-30 |
Kiichi Otani
PSD | President | 72 | 80-06-30 |
| Director/Board Member | 64 | 86-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.66% | 12 M€ | +7.42% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 5,946 | +2.04% | 128 300 |
| 24-05-23 | 5,827 | -0.31% | 103,400 |
| 24-05-22 | 5,845 | +0.05% | 136,200 |
| 24-05-21 | 5,842 | -1.03% | 97,900 |
| 24-05-20 | 5,903 | -0.46% | 69,400 |
Delayed Quote Japan Exchange, May 24, 2024 at 02:00 am EDT
More quotes
Ain Holdings Inc, is a Japan-based company engaged in the operation of pharmacies and retail business. The Company has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
Sector
Drug Retailers
Calendar
2024-06-03
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
5,827
JPY
Average target price
5,375
JPY
Spread / Average Target
-7.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +32.90% | 1.3B | |
| -10.08% | 348M | |
| +2.72% | 276M | |
| +12.22% | 230M | |
| -9.17% | 86.78M | |
| -46.56% | 82.4M | |
| +24.48% | 59.83M |
- Stock Market
- Equities
- 9627 Stock
